Unit-Linked / MSIG Life Indonesia
Sinarmas Optima Plus
★ The Insurer’s Play
analytical interpretationLimited read — analysis pending. Likely intent: grow fee-bearing investment balances alongside protection. Full read pending a Strategic Brief.
Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.
Who this fits — and who it doesn’t
Fit guidance becomes available once this product has a Strategic Brief.
Expert · technical detail
How Unit-Linked products differ
Still building · 55% coverageNo product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.
Top-up (Premi Investasi Tunggal) minimum observed at Rp 1,500,000 (Sun Solusi Bijak)
PAYDI death benefit is typically 100% UP + investment value; UP set as a multiple of premium, not a fixed schedule
Observed: 99 · 100
Conventional PAYDI in this set run to age 99 (AIA MILA Plus, MVP, Bahagia Bersama) or age 100 (Sun Solusi Bijak)
Front-loaded acquisition charge is the dominant early-year drag and the root cause of weak years 1-5 surrender; industry-typical band for agency PAYDI is ~40-100% spread across years 1-3
Admin fee is flat-rupiah and erodes small funds proportionally more
Annual fund management charge; lower = better. Sharia siblings observed up to ~2.6% ujrah (2026-06-04 run)
Surrender/withdrawal is punitive in early years across the category; the year 1-5 trap is the central mis-selling exposure
Persistency bonuses partially offset front-loaded fees but only reward customers who do not surrender early
Analyst observations (9)
- Post POJK 5/2022 (PAYDI) era — every active unit-linked product carries Risk-Based Investment Allocation, Quality of Service Standard, Fund Disclosure obligations.
- Three structural archetypes: (a) Regular premium top-up (Maxi / SmiLink / Solusi Bijak family — most prevalent), (b) Single premium investment-oriented (X-Tra Invest / Maxima Anugerah family), (c) Hybrid term-payment with locked-in benefits.
- Acquisition-charge front-loading is universal: years 1-5 typically 80-110% of basic premium consumed by acquisition + admin in regular-premium PAYDI products. Post-Y5 acquisition drops to 0% — driving the well-known 'invest after year 5' guidance.
- Top-up premium is the conventional escape valve to avoid the acquisition-charge ratchet — typically 4-5% fee only, allocated 100% to fund.
- Sharia UL products use Akad Wakalah bil Ujrah (single-fee) or Wakalah + Tabarru' (split-fee) — both disclosed clearly in RIPLAY Akad sections.
- USD-denominated UL has narrow availability — primarily Sun Life X-Tra Wealth Link USD, Salam Hijrah Arafah USD; positioned for affluent cross-border (Singapore/JB-Iskandar) buyers.
- Premium holiday is universally supported but resets surrender-charge clock; CSV during holiday remains charged.
- Allianz LegacyPro (USD non-PAYDI life) sits adjacent to this category — competitive substitute when customer wants guaranteed-cash-value without market exposure.
- Insurer-level patterns: Manulife dominates the count (14 of 42), Sun Life and TMLI mid-tier (3-5), Sharia coverage thin (6 of 42).
Coverage caveat: Unit-linked (PAYDI) per-product detail extraction remains ~11-18% across the 55 catalogued unit-linked entries (agency + dual-channel). Cross-product comparison in Section 5 of any unit-linked brief produced this run relies on qualitative observation plus structured peer references: the three Sun Life Syariah PAYDI briefs (maxima-anugerah, salam-hijrah-amanah-prima, manulife-mismart-syariah) produced 2026-06-04, and the four conventional PAYDI products analysed this run (sun-solusi-bijak, aia-bahagia-bersama, aia-mila-plus, aia-maxi-value-protection). Quantitative population statistics will firm up once unit-linked PDF coverage exceeds 60%. (sample: ~10 products)
Expert · full Strategic Brief
No Strategic Brief yet for this product — analysis pending.
Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.